Updated: SEC chair denies a deal to prevent Chinese company delisting is close — reports
The SEC chair is reportedly throwing cold water on US and Chinese regulators reaching a deal that would prevent hundreds of firms from being delisted on American stock exchanges, including biotech and pharma companies, despite rumors to the contrary.
SEC boss Gary Gensler said late Tuesday he is not sure when a deal might be reached to stave off the delistings, Bloomberg reported, even as he noted progress had been made. US regulators had been aiming to conduct more aggressive audits with the Chinese companies, a move he says China’s government has resisted.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
